CONTINGENT CONSIDERATION AND INTANGIBLE ASSET (Details Narrative) - USD ($) $ in Thousands |
6 Months Ended | |
|---|---|---|
Oct. 20, 2025 |
Jun. 30, 2026 |
|
| Contingent consideration | $ 54 | |
| Accrued expenses and other payables | 1,546 | |
| Ciro Leonardo Pierri [Member] | Maximum [Member] | ||
| Maximum amount payable | $ 1,600 | $ 1,600 |
| MitoCareX Bio Ltd [Member] | ||
| Shares issued for acquisitions | 139,520 | 34,880 |
| Business combination consideration | $ 385 | |
| MitoCareX Bio Ltd [Member] | Ciro Leonardo Pierri [Member] | ||
| Sale of stock percentage | 30.00% | |
| MitoCareX Bio Ltd [Member] | ||
| Subsidiary, ownership percentage, parent | 25.00% |
| X | ||||||||||
- Definition Amount of equity interests of the acquirer, including instruments or interests issued or issuable in consideration for the business combination. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of liability recognized arising from contingent consideration in a business combination. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition The parent entity's interest in net assets of the subsidiary, expressed as a percentage. No definition available.
|
| X | ||||||||||
- Definition Amount of liabilities incurred and payable to vendors for goods and services received classified as other, and expenses incurred but not yet paid, payable within one year or the operating cycle, if longer. No definition available.
|
| X | ||||||||||
- Definition Amount of long-term notes payable classified as other. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Percentage of subsidiary's or equity investee's stock owned by parent company after stock transaction. No definition available.
|
| X | ||||||||||
- Definition Number of shares of stock issued during the period pursuant to acquisitions. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|